Antibody responses to mRNA, adenovirus vector, and inactivated COVID-19 vaccines all demonstrated that lower CD4 count (<200/μl) or detectable viral loads were the risk factors for lower nAbs levels among PLWH (18, 21, 22). Here, CD4 is linked to COVID-19.